Share Name Share Symbol Market Type Share ISIN Share Description
Silence Therapeutics Plc LSE:SLN London Ordinary Share GB00B9GTXM62 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +16.00p +6.67% 256.00p 252.00p 256.00p 256.00p 240.00p 240.00p 589,129 16:35:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -20.5 -26.2 - 200

Silence Therapeutics Share Discussion Threads

Showing 50401 to 50424 of 50825 messages
Chat Pages: Latest  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011  2010  Older
DateSubjectAuthorDiscuss
12/11/2018
15:21
I'm gonna top up around there too
djnzloop
12/11/2018
14:51
Looks like I might get 80p sooner than I thought
volsung
10/11/2018
06:00
The latest MIT Technology Review: Vol 121 No.6 Nov/Dec 2018 - "The Precision Medicine Issue" makes fascinating reading for anyone with an interest in healthcare trends. Could well inform investing decisions too :)
multibagger
09/11/2018
16:26
Roll on December and a settlement on the courtroom steps?
1gw
09/11/2018
16:05
Back under a quid now. Maybe get my next lot at 80p
volsung
07/11/2018
09:07
Surprised to see the shares drifting lower given that there should be at least 3 newsflow events in next 6 weeks; (a) commencement of Court case against Alnylam (b) application submitted for phase 1 trial (3) results published from the Quark QPI-1002 trial
callumross
02/11/2018
15:56
So it seems. I still take the ex CEO adding recently as a sign something is going on behind the scenes.
waterloo01
02/11/2018
15:47
Guess the rumours have died down then. Oh well. Back to porridge
volsung
27/10/2018
13:10
Still struggle to see why anyone other than Alny would make a move before the Alny patent dispute is resolved. Perhaps that is thought to be near enough now that someone is putting a deal team together with a view to moving quickly once that resolution is announced - perhaps even looking at the possibility of putting a counter-offer on the table if resolution looks like Alny buying SLN?
1gw
26/10/2018
16:21
(H/T FT AV) Amicus Therapeutics (Nasdaq FOLD) Possible name in the frame then.........
soundbuy
24/10/2018
18:38
Maybe some substance to the story. Alphaville is a bit more plausible than some of the so called tipsters
callumross
24/10/2018
18:17
My bad ., forget it
djnzloop
24/10/2018
18:16
Lots of trading activity appearing now
djnzloop
24/10/2018
15:31
"Shares in Silence Therapeutics PLC (LON:SLN) surged in early afternoon trading on rumours that the RNA interference specialist is being eyed up by potential buyers in the US. FTAlphaville said there seems to be “some gossip around right now about interest in Silence from the US”. It added that the biotech industry in the US is clustered around San Diego, name checking Cidara Therapeutics, although its market cap is smaller than Silence’s. FTAlphaville does caveat the story though, saying it is “just a rumour at this stage, so needs a RAW disclaimer”. Still, it got the market excited, with Silence immediately climbing 11.4% to 123.7p."
callumross
24/10/2018
14:03
Looking good. If this rise continues, at what point will it require comment from the company I wonder?
1gw
24/10/2018
12:52
Fingers crossed for substance then. Thanks from me too. Not long until they're scheduled to be in court for the patent litigation so now would be an obvious time for discussions with Alnylam to come to a head. I would have thought anyone other than Alny might want to wait until after the patent litigation was settled though - unless they were convinced that Silence was likely to win big.
1gw
24/10/2018
12:05
Thanks for this Tony. They would have to pay way, way more than the current price, that's for sure!
callumross
24/10/2018
11:55
bid target? https://ftalphaville.ft.com/marketslive/2018-10-24/ 11:34 am BE Okay, so here's a thing. 11:36 am Silence Therapeutics PLC (SLN:LSE): Last: 112.00, up 1 (+0.90%), Volume: 7.96k 11:36 am BE Always been one of the more interesting biotech stories in the smallcaps. 11:37 am BE RNAi therapies progressing towards approval, reasonable amount of cash, new management in place .... 11:38 am BE ........ legal stuff gradually resolving. 11:38 am BE Now, there seems to be some gossip around right now about interest in Silence from the US. 11:39 am BE The industry over there is clustered towards San Diego, with Nasdaq-listed Cidara among the bigger players. 11:40 am BE Just a rumour at this stage, though, so needs a RAW disclaimer. 11:41 am RAW is market chatter - information that has not been formally tested through traditional journalistic channels (PRs etc). The story might be complete rubbish, but if we believe there is some substance to it we will say so. Either way, Reader Beware.
tonysss13
12/10/2018
18:32
erratum in deed!
waterloo01
12/10/2018
17:23
Now that's an interesting mistake. I had a moment's panic when I read about the placing! But CAKE and SLN appear to have different brokers, so I'm not sure it can be taken as an indication that SLN are expecting to put out an RNS imminently, on raising funds, settling litigation or anything else. But how do you put out a CAKE RNS under the SLN name?
1gw
12/10/2018
08:16
Cant imagine why anybody would sell up at the moment, the news all appears very positive ,must make sense to hang around for a couple of months and let the story play out .
partner
11/10/2018
12:48
Yes, not the best day to announce what is undoubtedly good news. The news yesterday re seeking injunctive relief suggests that ALNY are either unwilling or reluctant to settle, though.
callumross
11/10/2018
12:30
I expect them to settle before the hearing. Could be any day, but the ex CEO purchase seems a good indicator it might be sooner rather than later. After all they have enough cash! Added a few this week and good to see the price hold firm in this correction.
waterloo01
11/10/2018
10:32
Very encouraging preliminary result, putting more pressure on ALNY in addition to the injunctive action against Patisiran announced yesterday. If their first commercial product cannot be sold in the EU pending clarification on the SLN action, now that really would pressurize them to settle.
callumross
Chat Pages: Latest  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011  2010  Older
Your Recent History
LSE
SLN
Silence Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191020 20:35:42